These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 18294330

  • 21. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M, Sunagawa S, Kagaya H, Yasui-Furukori N, Uno T.
    Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
    [Abstract] [Full Text] [Related]

  • 22. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
    Saruwatari J, Yasui-Furukori N, Niioka T, Akamine Y, Takashima A, Kaneko S, Uno T.
    J Clin Psychopharmacol; 2012 Apr; 32(2):195-9. PubMed ID: 22367658
    [Abstract] [Full Text] [Related]

  • 23. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N, Uno T, Sugawara K, Tateishi T.
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of breviscapine and C3435T MDR1 gene polymorphism on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers.
    Zhao Y, Miao Z, Jiang M, Zhou X, Lai Y.
    Xenobiotica; 2021 Mar; 51(3):366-372. PubMed ID: 33256506
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide.
    Niemi M, Tornio A, Pasanen MK, Fredrikson H, Neuvonen PJ, Backman JT.
    Eur J Clin Pharmacol; 2006 Jun; 62(6):463-72. PubMed ID: 16758263
    [Abstract] [Full Text] [Related]

  • 29. Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants.
    Malati CY, Robertson SM, Hunt JD, Chairez C, Alfaro RM, Kovacs JA, Penzak SR.
    J Clin Pharmacol; 2012 Jun; 52(6):932-9. PubMed ID: 21646440
    [Abstract] [Full Text] [Related]

  • 30. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
    Dresser GK, Kim RB, Bailey DG.
    Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
    Russell T, Stoltz M, Weir S.
    Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
    [Abstract] [Full Text] [Related]

  • 32. Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics.
    Yamada S, Yasui-Furukori N, Akamine Y, Kaneko S, Uno T.
    Ther Drug Monit; 2009 Dec; 31(6):764-8. PubMed ID: 19855315
    [Abstract] [Full Text] [Related]

  • 33. Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.
    Yamazaki A, Kumagai Y, Yamane N, Tozuka Z, Sugiyama Y, Fujita T, Yokota S, Maeda M.
    J Clin Pharm Ther; 2010 Apr; 35(2):169-75. PubMed ID: 20456735
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.
    Lappin G, Shishikura Y, Jochemsen R, Weaver RJ, Gesson C, Houston B, Oosterhuis B, Bjerrum OJ, Rowland M, Garner C.
    Eur J Pharm Sci; 2010 May 12; 40(2):125-31. PubMed ID: 20307657
    [Abstract] [Full Text] [Related]

  • 36. Influence of P-glycoprotein on the disposition of fexofenadine and its enantiomers.
    Li F, Howard KD, Myers MJ.
    J Pharm Pharmacol; 2017 Mar 12; 69(3):274-284. PubMed ID: 28090646
    [Abstract] [Full Text] [Related]

  • 37. The effects of fexofenadine at steady-state on sleep architecture: a study using polysomnography in healthy Korean volunteers.
    Lee HW, Lee HW, Park DJ, Moon SO, Ahn JH, Kim MJ, Kim SD, Kim JE, Yoon YR.
    Expert Opin Pharmacother; 2008 Jul 12; 9(10):1655-65. PubMed ID: 18570599
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
    Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB.
    Clin Pharmacol Ther; 2002 Jan 12; 71(1):11-20. PubMed ID: 11823753
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.